CytarabineIdarubicinDaunorubicinLeukemia, Myeloid, AcuteRemission InductionConsolidation ChemotherapyAntineoplastic Combined Chemotherapy ProtocolsMitoxantroneAntimetabolites, AntineoplasticArabinonucleosidesLeukemia, MyeloidEtoposideThioguanineDrug Administration ScheduleMethotrexateInduction ChemotherapyVincristineTreatment OutcomeMeningeal CarcinomatosisPrecursor Cell Lymphoblastic Leukemia-LymphomaInjections, SpinalLeukemic InfiltrationCytidine MonophosphateAcute DiseaseCarmustineAsparaginaseDrug AgonismDisease-Free SurvivalDeoxycytidine KinaseLymphoma, Non-HodgkinLeukemia, Myelomonocytic, Acute6-MercaptopurineCyclophosphamideArabinonucleotidesLeukemia, Myeloid, Accelerated PhaseSurvival AnalysisRecurrenceCentral Nervous System NeoplasmsAmsacrineSurvival RateSalvage TherapyVidarabineArabinofuranosylcytosine TriphosphateTransplantation, AutologousLeukemia, Myelogenous, Chronic, BCR-ABL PositiveTeniposideAnemia, Refractory, with Excess of BlastsDoxorubicinMyelodysplastic SyndromesDexamethasoneCombined Modality TherapyLeukemiaMeningitisMelphalanPodophyllotoxinCladribineLeukemia, Myeloid, Chronic-PhaseDrug Resistance, NeoplasmAntineoplastic AgentsBlast CrisisAdenine NucleotidesInfusions, IntravenousPrednisoneDioxolanesPolyradiculopathyHarringtoninesAclarubicinActuarial AnalysisPrognosisHematopoietic Stem Cell TransplantationCytogenetic AnalysisBurkitt LymphomaMeningesGranulocyte Colony-Stimulating FactorBenzamidesEquilibrative Nucleoside Transporter 1PyrimidinesDose-Response Relationship, DrugPiperazinesCore Binding FactorsLeukemia, Promyelocytic, AcuteBone Marrow TransplantationLeukoencephalopathy, Progressive MultifocalLymphoma, Mantle-CellAminoglycosidesPapilledemaAntibodies, Monoclonal, Murine-DerivedAzacitidineDrug SynergismLymphomaNucleoside Transport ProteinsInterferon-alphaAnthracyclinesCytogeneticsBenzenesulfonatesDrug EvaluationCranial Irradiation